FLT3 and leukemia: It was a tremendous surprise when my oncologist called me about a week later to tell me that Malachi had identified a clinically actionable target from the RNA-seq data: My leukemia cells were massively overexpressing wild-type FLT3, a receptor tyrosine kinase important for hematopoietic cell survival, development, and proliferation.